STEPHANIE RODRIGUEZ: Open Payments
NPI 1164291787 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,254 in 57 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $257 · 2025 $1,254
Food & beverage: $1,254
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $574 |
| Janssen Biotech, Inc. | 9 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $110 |
| Ardelyx, Inc. | 1 | $110 |
| Phathom Pharmaceuticals, Inc. | 7 | $77 |
| Intercept Pharmaceuticals, Inc. | 3 | $73 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $42 |
| Gilead Sciences, Inc. | 1 | $33 |
| Lilly USA, LLC | 1 | $23 |
| VIVUS LLC | 1 | $16 |
Products named: RINVOQ, TREMFYA, CREON, IBSRELA, LINZESS, ENTYVIO, VOQUEZNA, OCALIVA.
Industry payments across FL — which companies pay providers there.
